Oct 6, 2026 11:15AM
Oct 6, 2026 11:15AM
Aug 21, 2026 07:00AM
Jul 21, 2026 07:13AM
Jul 21, 2026 07:13AM
Jul 21, 2026 07:00AM
Jul 21, 2026 07:00AM PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002
Jul 7, 2026 08:59AM
Jul 7, 2026 08:58AM
May 27, 2026 07:30AM
May 27, 2026 07:30AM
May 20, 2026 08:15AM
May 20, 2026 07:44AM
May 20, 2026 07:38AM Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
Apr 7, 2026 12:35PM
Apr 7, 2026 08:14AM
Apr 7, 2026 08:00AM
Apr 7, 2026 08:00AM
Mar 2, 2026 08:00AM
Feb 12, 2026 01:30PM
Dec 16, 2025 10:31AM Jupiter Neurosciences receives FDA clearance for Parkinson's trial
Dec 16, 2025 10:30AM
Dec 3, 2025 08:00AM
Nov 5, 2025 08:30AM
Nov 5, 2025 08:30AM

334,874 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All